-
Posted by
Two Blokes May 21, 2025 -
Filed in
Stock
-
2 views
Entering trading this week, shares of Iovance Biotherapeutics (IOVA 4.10%) have crashed by nearly 78% since the start of the year. It has been an abysmal start to 2025 for a company that does possess some attractive long-term growth prospects.